Skip to main content

Table 2 Odds ratios and 95% confidence intervals for eczema according to IL13 polymorphisms in Japanese women

From: IL13genetic polymorphisms, smoking, and eczema in women: a case-control study in Japan

SNP

Model

Genotype

Cases n(%)

Controls n(%)

Crude OR (95% CI)

Adjusted OR (95% CI)*

rs1800925

  

(N = 188)

(N = 1,082)

  
 

Co-dominant

CC

122 (64.9)

717 (66.3)

1.00

1.00

  

CT

56 (29.8)

338 (31.2)

0.97 (0.69-1.37)

1.01 (0.71-1.42)

  

TT

10 (5.3)

27 (2.5)

2.18 (1.03-4.61)

2.19 (1.03-4.67)

 

Additive

   

1.15 (0.87-1.52)

1.18 (0.89-1.56)

 

Dominant

CC

122 (64.9)

717 (66.3)

1.00

1.00

  

CT + TT

66 (35.1)

365 (33.7)

1.06 (0.77-1.47)

1.10 (0.79-1.52)

 

Recessive

CC + CT

178 (94.7)

1,055 (97.5)

1.00

1.00

  

TT

10 (5.3)

27 (2.5)

2.20 (1.04-4.61)

2.19 (1.04-4.63)

rs20541

  

(N = 188)

(N = 1,081)

  
 

Co-dominant

GG

85 (45.2)

536 (49.6)

1.00

1.00

  

GA

82 (43.6)

448 (41.4)

1.15 (0.83-1.60)

1.16 (0.84-1.62)

  

AA

21 (11.2)

97 (9.0)

1.37 (0.81-2.31)

1.44 (0.85-2.44)

 

Additive

   

1.16 (0.92-1.47)

1.19 (0.94-1.50)

 

Dominant

GG

85 (45.2)

536 (49.6)

1.00

1.00

  

GA + AA

103 (54.8)

545 (50.4)

1.19 (0.87-1.63)

1.21 (0.89-1.66)

 

Recessive

GG + GA

167 (88.8)

984 (91.0)

1.00

1.00

  

AA

21 (11.2)

97 (9.0)

1.28 (0.77-2.10)

1.34 (0.81-2.22)

  1. * Adjusted for age, region of residence, number of children, smoking, and education.